Anadolu Medical Center
Anadolu Medical Center
Turkey, Istanbul
Zafer Gulbas
49 years of experience • 3315+ treatments performed
accreditations :
Clinic is certified :
Dr. Zafer Gulbas founded and directs Turkey’s largest Bone Marrow Transplant Center at Anadolu Medical Center. He is a hematologist-oncologist specializing in complex blood cancers and clotting disorders. Dr. Gulbas trained at top global institutions, including MD Anderson and Fred Hutchinson in the USA. He performs autologous and allogeneic transplants for leukemia, lymphoma, and aplastic anemia.
Dr. Serdar Bedii Omay is a hematologist-oncologist at Emsey Hospital in Istanbul. He has published over 60 scientific articles on hematology and bone marrow transplantation. Dr. Omay earned a PhD from Mie Medical School in Japan. He treats adult and pediatric patients with complex blood disorders.
Dr. Betul Tavil is a professor of pediatric hematology and oncology at Memorial Şişli Hospital. She has successfully treated 500+ children with leukemia. Dr. Tavil is an expert in bone marrow transplantation for complex cases. She manages rare blood disorders, including congenital erythropoietic porphyria and immunodeficiencies. Memorial Şişli Hospital is JCI-accredited and maintains a 90% organ transplant success rate.
Dr. Mehmet Hilmi Dogu is a hematologist at Liv Hospital Ulus in Istanbul. He is a board member of the Society of Hematological Education and Research. Dr. Dogu authored 32 international peer-reviewed articles on hematology. He specializes in treating chronic leukemia, lymphomas, and multiple myeloma.
Turkish hematology centers offer comprehensive treatments for hemolytic anemia, including bone marrow transplants, immunosuppressive therapy, and surgical splenectomy. Specialized units at JCI-accredited clinics like Anadolu Medical Center and Medipol Mega provide definitive curative options for inherited conditions like sickle cell and thalassemia through advanced stem cell transplantation.
Bookimed Expert Insight: Turkey stands out for scale, with units like Medipol Mega and Emsey Hospital operating 45-bed bone marrow transplant centers. This high capacity allows Professor Dr. Zafer Gulbas at Anadolu to maintain an 81% success rate for autologous transplants. Patients often choose these centers because they combine high-volume experience with direct affiliations to major US medical institutions.
Patient Consensus: Patients emphasize the need for a precise hematology workup first, as the specific cause determines whether they receive steroids or a transfusion. Many note that while transfusions bring immediate relief, consistent follow-up testing is essential because the underlying hemolysis may still be active.
Turkish hospitals utilize high-resolution hemoglobin electrophoresis and direct antiglobulin tests to identify hemolytic anemia types. JCI-accredited centers in Istanbul perform advanced flow cytometry and genetic panels to distinguish between inherited and acquired disorders. Diagnosis often involves board-certified hematologists from institutions like Anadolu Medical Center.
Bookimed Expert Insight: While many general hospitals provide basic blood counts, centers like Anadolu Medical Center and Medipol Mega offer specialized Bone Marrow Transplant units and flow cytometry. These facilities handle a massive volume of complex blood disorders annually. Choosing a clinic with an integrated flow cytometry lab ensures faster results for rare hemolytic subtypes.
Patient Consensus: Patients emphasize the importance of requesting a complete hemolysis panel early. They also note that recent blood transfusions can sometimes interfere with testing accuracy.
Bone marrow transplant (BMT) is used in Turkey as a curative treatment for severe hemolytic anemias. Specialists perform this procedure for inherited conditions like thalassemia major and sickle cell disease. JCI-accredited centers in Istanbul provide these complex hematopoietic stem cell transplants for children and adults.
Bookimed Expert Insight: While many view BMT as a general procedure, Turkish centers like Medipol Mega and Emsey Hospital offer specialized pediatric-focused units. This specialization is critical because inherited hemolytic anemias are often diagnosed in childhood. Choosing a center with a large bed capacity typically ensures shorter waiting times for life-saving donor matching.
Patient Consensus: Patients emphasize that a precise subtype diagnosis is necessary before considering a transplant. They mention that Turkish hematologists focus on BMT as a last-resort but potentially curative option for severe disease.